Pancratistatin induces apoptosis and autophagy in metastatic prostate cancer cells

International Journal of Oncology

Volumn 38, Issue 6, 2011, Pages 1549-1556

  Griffin, Carly ^a   McNulty, James ^b   Pandey, Siyaram ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Androgen independent; DU145 xenograft; Mitochondria; Reactive oxygen species

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; PANCRATISTATIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CELL MIGRATION; CELL STRAIN LNCAP; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG TOLERABILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MICROSCOPY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR XENOGRAFT; WESTERN BLOTTING;

AMARYLLIDACEAE ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CASPASES; CELL LINE; CELL MOVEMENT; ENZYME ACTIVATION; HUMANS; ISOQUINOLINES; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, NUDE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79955787711     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.977     Document Type: Article

References (32)

1. Kornienko A and Evidente A: Chemistry, biology, and medicinal potential of narciclasine and its congeners. Chem Rev 108: 1982-2014, 2008.
2. Griffin C, Karnik A, McNulty J and Pandey S: Pancratistatin selectively targets cancer cell mitochondria and reduces growth of human colon tumor xenografts. Mol Cancer Ther 10: 57-68, 2011.
3. Kekre N, Griffin C, McNulty J and Pandey S: Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemother Pharmacol 56: 29-38, 2005. (Pubitemid 41201753)
4. Chatterjee SJ, McNulty J and Pandey S: Sensitization of human melanoma cells by tamoxifen to apoptosis induction by pancratistatin, a nongenotoxic natural compound. Melanoma Res (In press).
5. Siedlakowski P, McLachlan-Burgess A, Griffin C, Tirumalai SS, McNulty J and Pandey S: Synergy of pancratistatin and tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria. Cancer Biol Ther 7: 376-384, 2007.
6. Ralph SJ, Rodríguez-Enríquez S, Neuzil J and Moreno-Sánchez R: Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol Aspects Med 31: 29-59, 2010.
7. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M and Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84, 2007. (Pubitemid 44566469)
8. Fulda S, Galluzzi L and Kroemer G: Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9: 447-464, 2010.
9. Liu EH, Qi LW, Wu Q, Peng YB and Li P: Anticancer agents derived from natural products. Mini Rev Med Chem 9: 1547-1555, 2009.
10. Neuzil J, Wang XF, Dong LF, Low P and Ralph SJ: Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett 580: 5125-5129, 2006. (Pubitemid 44415781)
11. Dong LF, Freeman R, Liu J, Zobalova R, Marin-Hernandez A, Stantic M, Rohlena J, Valis K, Rodriguez-Enriquez S, Butcher B, Goodwin J, Brunk UT, Witting PK, Moreno-Sanchez R, Scheffler IE, Ralph SJ and Neuzil J: Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II. Clin Cancer Res 15: 1593-1600, 2009.
12. Xiao D, Powolny AA, Moura MB, Kelley EE, Bommareddy A, Kim SH, Hahm ER, Normolle D, van Houten B and Singh SV: Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells. J Biol Chem 285: 26558-26569, 2010.
13. DiPaola RS, Dvorzhinski D, Thalasila A, Garikapaty V, Doram D, May M, Bray K, Mathew R, Beaudoin B, Karp C, Stein M, Foran DJ and White E: Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy. Prostate 68: 1743-1752, 2008.
14. Fimia GM and Piacentini M: Regulation of autophagy in mammals and its interplay with apoptosis. Cell Mol Life Sci 67: 1581-1588, 2010.
15. Dalby KN, Tekedereli I, Lopez-Berestein G and Ozpolat B: Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 6: 322-329, 2010.
16. Qadir MA, Kwok B, Dragowska WH, To KH, Le D, Bally MB and Gorski SM: Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat 112: 389-403, 2008.
17. Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC and Kroemer G: Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta 1793: 1524-1532, 2009.
18. Gibson SB: A matter of balance between life and death: targeting reactive oxygen species (ROS)-induced autophagy for cancer therapy. Autophagy 6: 835-837, 2010.
19. White E and DiPaola RS: The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15: 5308-5316, 2009.
20. Olovnikova IA, Kravchenkoa JE and Chumakov PM: Homeostatic functions of the p53 tumor suppressor: Regulation of energy metabolism and antioxidant defence. Sem Can Biol 19: 32-41, 2009.
21. Radhakrishnan S, Miranda E, Ekblad M, Holford A, Pizarro MT, Lemoine NR and Halldén G: Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenografts. Hum Gene Ther 21: 1311-1325, 2010.
22. McNulty J, Mao J, Gibe R, Mo R, Wolf S, Pettit GR, Herald DL and Boyd MR: Studies directed towards the refinement of the pancratistatin cytotoxic pharmacophore. Bioorg Med Chem Lett 11: 169-172, 2001. (Pubitemid 32099633)
23. Hu H, Lee HJ, Jiang C, Zhang J, Wang L, Zhao Y, Xiang Q, Lee EO, Kim SH and Lü J: Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Mol Cancer Ther 7: 2681-2691, 2008.
24. Gabrielsen B, Monath TP, Huggins JW, Kefauver DF, Pettit GR, Groszek G, Hollingshead M, Kirsi JJ, Shannon WM and Schubert EM: Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances. J Nat Prod 55: 1569-1581, 1992.
25. Shah MR, Kriedt CL, Lents NH, Hoyer MK, Jamaluddin N, Klein C and Baldassare J: Direct intra-tumoral injection of zinc-acetate halts tumor growth in a xenograft model of prostate cancer. J Exp Clin Cancer Res 28: 84, 2009.
26. Griffin C, Hamm C, McNulty J and Pandey S: Pancratistatin induces apoptosis in clinical leukemia samples with minimal effect on non-cancerous peripheral blood mononuclear cells. Cancer Cell Int 10: 6, 2010.
27. Wang F, Ogasawara MA and Huang P: Small mitochondria-targeting molecules as anti-cancer agents. Mol Asp Med 31: 75-92, 2010.
28. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
29. Levine B: Cell biology: Autophagy and cancer. Nature Q&A 446: 745-747, 2007.
30. Galluzzi L, Morselli E, Kepp O, Vitale I, Pinti M and Kroemer G: Mitochondrial liaisons of p53. Antioxid Redox Signal (In press).
31. Green DR and Kroemer G: Cytoplasmic functions of the tumour suppressor p53. Nature 458: 1127-1130, 2009.
32. Alirol E and Martinou JC: Mitochondria and cancer: is there a morphological connection? Oncogene 25: 4706-4716, 2006.